This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Laurus Labs Private Limited. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Innovations of Srinivas Lagadapati in Pharmaceutical Chemistry
Introduction
Srinivas Lagadapati is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative processes for drug preparation. His work is characterized by a focus on improving the efficacy and formulation of pharmaceutical compounds.
Latest Patents
Srinivas Lagadapati holds a patent for the "Process for preparation of empagliflozin or its co-crystals, solvates and their polymorphs thereof." This invention relates to a novel method for preparing Empagliflozin, a medication used to treat type 2 diabetes. The patent also covers the preparation of various forms of the drug, including amorphous and crystalline forms, as well as the intermediates used in the process.
Career Highlights
Srinivas is currently associated with Laurus Labs Private Limited, a prominent company in the pharmaceutical sector. His role involves research and development, where he applies his expertise to enhance drug formulations and processes. His innovative approach has led to advancements in the preparation of essential medications.
Collaborations
Srinivas has collaborated with several professionals in his field, including Uma Maheswar Rao Vasireddi and Sanjay Kumar Dehury. These collaborations have fostered a productive environment for innovation and have contributed to the success of various projects within the company.
Conclusion
Srinivas Lagadapati's contributions to pharmaceutical chemistry exemplify the impact of innovation in drug development. His patent for the preparation of Empagliflozin highlights his commitment to advancing medical science and improving patient outcomes. His work continues to inspire future innovations in the pharmaceutical industry.